Advance notification letters increase adherence in colorectal cancer screening: A population-based randomized trial

Aafke Roon, L Hal, Janneke Wilschut, JCIY Reijerink, Hanneke van Vuuren, Marjolein Ballegooijen, Dik Habbema, M Leerdam, Ernst Kuipers

Research output: Contribution to journalArticleAcademicpeer-review

47 Citations (Scopus)


Objective. The population benefit of screening depends not only on the effectiveness of the test, but also on adherence, which, for colorectal cancer (CRC) screening remains low. An advance notification letter may increase adherence, however, no population-based randomized trials have been conducted to provide evidence of this. Method. In 2008, a representative sample of the Dutch population (aged 50-74 years) was randomized. All 2493 invitees in group A were sent an advance notification letter, followed two weeks later by a standard invitation. The 2507 invitees in group B only received the standard invitation. Non-respondents in both groups were sent a reminder 6 weeks after the invitation. Results. The advance notification letters resulted in a significantly higher adherence (64.4% versus 61.1%, p-value 0.019). Multivariate logistic regression analysis showed no significant interactions between group and age, sex, or socio-economic status. Cost analysis showed that the incremental cost per additional detected advanced neoplasia due to sending an advance notification letter was (sic)957. Conclusion. This population-based randomized trial demonstrates that sending an advance notification letter significantly increases adherence by 3.3%. The incremental cost per additional detected advanced neoplasia is acceptable. We therefore recommend that such letters are incorporated within the standard CRC-screening invitation process. (C) 2011 Elsevier Inc. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)448-451
Number of pages4
JournalPreventive Medicine
Issue number6
Publication statusPublished - 2011

Cite this